Literature DB >> 6825083

Biochemical and antitumor effects of 5,8-dideazaisopteroylglutamate, a unique quinazoline inhibitor of thymidylate synthase.

D J Fernandes, J R Bertino, J B Hynes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6825083

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  4 in total

1.  Nobel lecture in physiology or medicine--1988. Selective inhibitors of dihydrofolate reductase.

Authors:  G H Hitchings
Journal:  In Vitro Cell Dev Biol       Date:  1989-04

2.  Experimental combination chemotherapy with thymidylate synthetase and ribonucleotide reductase inhibitors.

Authors:  S Kobayashi; T Hoshino; D V Santi
Journal:  Pharm Res       Date:  1984-07       Impact factor: 4.200

3.  Mutants of human colon adenocarcinoma, selected for thymidylate synthase deficiency.

Authors:  P J Houghton; G S Germain; B J Hazelton; J W Pennington; J A Houghton
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Effects of 5,8-dideazaisopteroylglutamate (IAHQ) on L1210 leukemia in mice when given alone and in combination with methotrexate, probenecid, or verapamil.

Authors:  J B Hynes; A B Smith; G R Gale
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.